Company Number: 14548224

Analysis Date: 2025-07-20 11:15 UTC

Financial Health Assessment of Gwynfa Limited as of 31 December 2023

---

1. Financial Health Score: D

Explanation:
Gwynfa Limited’s financial health currently reflects significant distress. The company shows negative net assets (equity) of approximately £25,795 and a large working capital deficit (net current liabilities of around £800,649). This suggests the company’s short-term obligations far exceed its liquid resources. While the company holds substantial fixed assets, chiefly investment property valued at over £1.15 million, the liquidity crunch and negative equity weigh heavily on its financial wellness, leading to a grade of D.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets	1,165,925	Healthy long-term asset base (investment property + tangible assets) providing asset backing.
Current Assets	10,589	Very low liquid resources; weak short-term asset base.
Cash at Bank	7,483	Minimal cash reserves; strained cash flow condition.
Current Liabilities	811,238	Very high short-term debts; significant immediate financial obligations.
Net Current Assets (Working Capital)	-800,649	Negative working capital indicates liquidity distress; company unable to cover short-term debts with current assets.
Total Assets Less Current Liabilities	365,276	Positive, supported by fixed assets, but offset by long-term liabilities.
Creditors due after one year	391,071	Long-term debt obligations add to financial leverage.
Net Assets (Equity)	-25,795	Negative equity signals insolvency on a balance sheet basis.
Directors’ Loan Account	809,883	Large amount owed to directors, interest-free and repayable on demand, indicating internal financing reliance.

---

3. Diagnosis: Financial Condition Analysis

• Liquidity Crisis (Symptoms of Distress): The company’s inability to cover its short-term liabilities with current assets (negative working capital of -£800k) is a red flag. This "cash flow anemia" suggests difficulty meeting immediate obligations, which could impede ongoing operations without external intervention or cash injections.

• Solvency Concerns (Underlying Disease): Negative net assets indicate that total liabilities exceed total assets, a symptom of insolvency on a balance sheet level. While fixed assets are substantial, much of the company’s funding is through debt, including significant loans from directors and bank loans.

• Asset Base (Potential Heartbeat): The large investment property asset provides some hope, as it can be leveraged or sold to improve liquidity. However, its illiquid nature means it cannot quickly alleviate cash flow issues.

• Financing Structure (Stressors): Heavy reliance on interest-free, repayable-on-demand directors’ loans suggests the business is dependent on internal financing to remain operational. This is often a temporary remedy and may not be sustainable long-term.

• Early Stage Consideration: Since the company was incorporated only in December 2022 and commenced trading in January 2023, the current financial state may reflect early-stage investments, asset acquisitions, and initial funding structure rather than established operational profit.

---

4. Recommendations: Prescriptions for Financial Wellness

1. Improve Liquidity:

   • Seek to refinance or restructure current liabilities to reduce short-term pressure.
   • Negotiate extended payment terms with creditors to convert some current liabilities into longer-term debt.
   • Explore short-term working capital facilities or bridging loans if necessary.

2. Utilize Asset Base:

   • Consider monetizing or leveraging the investment property to generate cash.
   • Evaluate the possibility of selling non-core assets or parts of the investment property portfolio.

3. Strengthen Equity:

   • Directors or shareholders could inject additional equity capital to eliminate negative net assets and restore balance sheet health.
   • Alternatively, explore external investors or partners for capital infusion.

4. Financial Management Controls:

   • Implement strict cash flow forecasting and monitoring to detect and address liquidity gaps early.
   • Develop a clear plan for repaying directors’ loans, as reliance on these may not be sustainable.

5. Operational Efficiency:

   • Review business model and operational costs to ensure cash flow generation improves as trading progresses.
   • Build a contingency plan for financial stress scenarios, including alternative funding options.

6. Regular Monitoring:

   • Maintain timely and accurate financial reporting to track progress on liquidity and solvency.
   • Engage financial advisors if needed to assist with restructuring and strategic planning.

---